Cok Groot's Contact Details

Cok Groot's Company Details

i+solutions

Woerden, Utrecht, Netherlands • 86 Employees
Pharmaceuticals

Our vision is a world where no medical need goes unmet. To achieve our vision, we partner with governmental, private sector, public and charitable organizations to develop health infrastructures to help low- and middle-income countries become resilient societies. Our mission is to save and improve lives by creating well-functioning health supply chains.We are the largest procurement service agent for the Global Fund's Pooled Procurement Mechanism. We are responsible for the procurement and logistics of Anti-retroviral, Anti-Malaria and Essential Medicines for over 70 countries. We supply constantly at an on-time and in-full delivery performance above 90% and contribute to the delivery of HIV treatment to over 4.6 million patients and malaria treatments to over 100 million patients.i+solutions is active in several projects that aim to solve bottlenecks in the access to medicines in low- and middle-income countries. Not only do we procure essential medicines and health products, we also strengthen public health systems by conducting training and consultancy activities so that countries can improve their internal capacity and eventually take full control of their pharmaceutical supply chain. We are active in various health programs such as HIV, TB, Malaria, vaccines, family planning, maternal health. We use innovative digital tools to improve the supply chain in countries. After implementing projects for 15 years in the global health supply chain across Africa, we have developed an innovation agenda. This ranges from a block chain pilot in the north of Nigeria to creating end-to-end visibility for optimizing supply chains with modelling and modern techniques such as machine learning. In 2020 we developed a whitepaper on how we believe global health supply chains can be improved through innovative new ideas. Impact by innovation!i+solutions is a non-profit foundation, based in Woerden, The Netherlands.